Publicaciones
Actualidad científica
27
Sep
Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells
Mauricio P. Pinto 3, Paula Sotomayor, Gonzalo Carrasco-Avino, Alejandro H. Corvalan and Gareth I. Owen
27
Sep
Evolutionary history of the reprimo tumor suppressor gene family in vertebrates with a description of a new reprimo gene lineage
Wichmann1, Zavala K, Hoffmann FG, Vandewege ,0MW, Corvalán AH, Amigo JD2, Owen GI, Opazo JC2
27
Sep
21
Sep
Venlafaxine treatment after endothelian-1-induced cortical stroke modulates growth factor expression and reduces tissue damage in ratl
Zepeda R1, Contreras V, Pissani C, Stack K, Vargas M, Owen GI, Lazo OM2, Bronfman FC2.
18
May
Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models
Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models, Lobos-González L.,Aguilar-Guzmán L.,Fernandez GJ.,Muñoz N.,Hossain M.,Bieneck S.,Silva V.,Burzio V.,Sviderskaya EV.,Bennett DC.,Leyton L.,Quest AFG, Melanoma Res, 2014, Volume 24, Pages 108-119
18
May
Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion.
Rab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasion, Díaz J.,Mendoza P.,Ortiz R.,Díaz N.,Leyton L.,Stupack D.,Quest AFG.,Torres V, J Cell Sci, 2014, Volume 127, Pages 2401-2406.